1. Home
  2. TNGX vs ODC Comparison

TNGX vs ODC Comparison

Compare TNGX & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • ODC
  • Stock Information
  • Founded
  • TNGX 2014
  • ODC 1941
  • Country
  • TNGX United States
  • ODC United States
  • Employees
  • TNGX N/A
  • ODC N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • TNGX Health Care
  • ODC Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • ODC Nasdaq
  • Market Cap
  • TNGX 317.4M
  • ODC 305.8M
  • IPO Year
  • TNGX N/A
  • ODC N/A
  • Fundamental
  • Price
  • TNGX $1.67
  • ODC $45.74
  • Analyst Decision
  • TNGX Strong Buy
  • ODC
  • Analyst Count
  • TNGX 7
  • ODC 0
  • Target Price
  • TNGX $12.33
  • ODC N/A
  • AVG Volume (30 Days)
  • TNGX 853.8K
  • ODC 56.0K
  • Earning Date
  • TNGX 05-07-2025
  • ODC 03-11-2025
  • Dividend Yield
  • TNGX N/A
  • ODC 1.35%
  • EPS Growth
  • TNGX N/A
  • ODC 18.90
  • EPS
  • TNGX N/A
  • ODC 3.13
  • Revenue
  • TNGX $42,069,000.00
  • ODC $465,340,000.00
  • Revenue This Year
  • TNGX N/A
  • ODC N/A
  • Revenue Next Year
  • TNGX N/A
  • ODC N/A
  • P/E Ratio
  • TNGX N/A
  • ODC $14.98
  • Revenue Growth
  • TNGX 15.17
  • ODC 8.24
  • 52 Week Low
  • TNGX $1.60
  • ODC $29.48
  • 52 Week High
  • TNGX $12.02
  • ODC $49.72
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 32.02
  • ODC 49.57
  • Support Level
  • TNGX $1.65
  • ODC $44.51
  • Resistance Level
  • TNGX $1.81
  • ODC $49.37
  • Average True Range (ATR)
  • TNGX 0.16
  • ODC 1.98
  • MACD
  • TNGX 0.01
  • ODC -0.25
  • Stochastic Oscillator
  • TNGX 8.57
  • ODC 23.61

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: